Caribou Biosciences (CRBU) Operating Income Growth (5y) (2025 - 2026)

Caribou Biosciences (CRBU) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	65,538.84 Bn	65,538.56 Bn	-
2	Nanobiotix	1,912.79 Bn	1,912.72 Bn	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
4	BeOne Medicines	469.46 Bn	464.67 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.69 Bn	115.45 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.41 Bn	61.65 Bn	3.31 Bn
7	Belite Bio	62.84 Bn	62.84 Bn	-
8	Argenx Se	56.10 Bn	50.91 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.48 Bn	34.47 Bn	959.66 Mn
10	Caribou Biosciences	154.82 Mn	37.19 Mn	-

Download Data